Person: MİRİOĞLU, ŞAFAK
Search Results
COVİD-19 infection in a membranous nephropathy patient treated with rituximab.
2020-09-04T00:00:00Z, Elcioglu, Omer Celal, Artan, Ayse Serra, Mirioglu, Safak, Gursu, Meltem, Durdu, Bulent, Koc, Meliha Meric, Okyaltirik, Fatmanur, Gultekin, Mehmet Ali, Kazancioglu, Rümeyza, ELÇİOĞLU, ÖMER CELAL, MİRİOĞLU, ŞAFAK, GÜRSU, MELTEM, DURDU, BÜLENT, MERİÇ KOÇ, MELİHA, OKYALTIRIK, FATMANUR, GÜLTEKİN, MEHMET ALİ, KAZANCIOĞLU, RÜMEYZA
While COVID-19 pandemic continues to afect our country and most countries in the world, we have to make some changes both in our social life and our approach to healthcare. We have to struggle with the pandemic on one hand and also try to follow up and treat our patients with chronic diseases in the most appropriate way. In this period, one of our group of patients who are challenging us for follow-up and treatment are those who should start or continue to use immunosuppressive therapy. In order to contribute to the accumulation of knowledge in this area, we wanted to report a patient who was followed up with the diagnosis of COVID-19 and had been administered rituximab very recently due to a nephrotic syndrome caused by membranous nephropathy.
Nadir Bir Kateter İlişkili Enfeksiyon Etkeni; Achromobacter Denitrificans
2022-11-09, Çıngar Alpay K., Gürsu M., Elçioğlu Ö. C., Mirioğlu Ş., Kazancıoğlu R., ÇINGAR, KÜBRA, GÜRSU, MELTEM, ELÇİOĞLU, ÖMER CELAL, MİRİOĞLU, ŞAFAK, KAZANCIOĞLU, RÜMEYZA
Covid-19 Pandemisinin Peritonit Hızı Üzerine Etkisi
2022-11-09, Gürsu M., Mirioğlu Ş., Köse E., Yücel L., Sayan C., Elçioğlu Ö. C., Kazancıoğlu R., GÜRSU, MELTEM, MİRİOĞLU, ŞAFAK, ELÇİOĞLU, ÖMER CELAL, KAZANCIOĞLU, RÜMEYZA